Progression of diabetic retinopathy after endophthalmitis

被引:20
作者
Dev, S
Pulido, JS
Tessler, HH
Mittra, RA
Han, DP
Mieler, WF
Connor, TB
机构
[1] Univ Illinois, Dept Ophthalmol, Chicago, IL 60612 USA
[2] Med Coll Wisconsin, Inst Eye, Vitreoretinal Sect, Milwaukee, WI 53226 USA
关键词
D O I
10.1016/S0161-6420(99)90166-5
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To determine the effect of endophthalmitis on diabetic retinopathy, Design: Noncomparative case series. Methods: The records of all consecutive patients with endophthalmitis treated between 1992 and 1997 at the Medical College of Wisconsin were retrospectively reviewed. Those patients with diabetes mellitus were analyzed. Participants: From 77 reviewed records, 11 patients (12 eyes; 14%) were identified as diabetics with endophthalmitis and were studied, Main Outcome Measures: Stage of diabetic retinopathy, time to retinopathy progression, and visual acuity, Results: Mean patient age was 68 years, and mean duration of diabetes was 11.7 years. Mean patient follow-up was 17 months. Of the six Gases without evidence of retinopathy before the endophthalmitis, none went on to develop retinopathy, Of six eyes with pre-existing nonproliferative retinopathy, four showed evidence of progression within 6 months of the infection. Three developed severe proliferative disease and macular edema, and one developed severe nonproliferative disease. More patients without pre-existing retinopathy achieved a final Visual acuity of 20/40 or greater, Conclusions: Patients with pre-existing diabetic retinopathy may be at increased risk for vapid retinopathy progression and a poorer visual outcome after endophthalmitis, These results support the concept that inflammation may exacerbate diabetic retinopathy.
引用
收藏
页码:774 / 781
页数:8
相关论文
共 60 条
[1]   FC RECEPTOR-MEDIATED PHAGOCYTOSIS - ABNORMALITIES ASSOCIATED WITH DIABETES-MELLITUS [J].
ABRASS, CK .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 58 (01) :1-17
[2]  
AIELLO LM, 1983, OPHTHALMOLOGY, V90, P814
[3]  
AIELLO LM, 1969, PUBLIC HLTH SERVICE, V1890
[4]  
ALKASSAB AS, 1990, CLIN EXP IMMUNOL, V81, P267
[5]  
[Anonymous], 1991, OPHTHALMOLOGY, V98, P823
[6]  
[Anonymous], 1995, Arch Ophthalmol, V113, P1479
[7]  
[Anonymous], 1995, DIABETES, V44, P968
[8]   INCREASED LIPID PEROXIDE LEVELS AND MYELOPEROXIDASE ACTIVITY IN THE VITREOUS OF PATIENTS SUFFERING FROM PROLIFERATIVE DIABETIC-RETINOPATHY [J].
AUGUSTIN, AJ ;
BREIPOHL, W ;
BOKER, T ;
LUTZ, J ;
SPITZNAS, M .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1993, 231 (11) :647-650
[9]  
Becker B, 1967, VASCULAR COMPLICATIO, P43
[10]  
BENSON WE, 1993, OPHTHALMOLOGY, V100, P730